Clik here to view.
A Piece of a Puzzle – The All of Us Research Program and Cancer
A recent article discusses the promise of precision medicine research for cancer prevention and control in the National Institutes of Health (NIH)’s All of Us research program. In 2015, then-President...
View ArticleClik here to view.
Rare Primary Immunodeficiency Diseases and COVID-19: Evolving Insights and...
In this post, we explore how new research on rare genetic diseases is contributing to our understanding of COVID-19 occurrence and outcomes and discuss potential clinical and public health...
View ArticleClik here to view.
Tracking the Impact of the All of Us Research Program: The All of Us Reports...
The All of Us Reports and Publications Database (AofURPD) is a continuously updated, searchable database referencing and linking to peer reviewed journal publications, preprint records, as well as...
View ArticleClik here to view.
Cost-effectiveness of Pharmacogenomic Testing: How to Measure the Value of...
A recent systematic review that assessed the cost-effectiveness of pharmacogenetic testing for drugs with existing guidelines concluded that most studies favored pharmacogenomic testing. The...
View ArticleClik here to view.
Tracking the Contributions of Implementation Science to the Population Health...
Successful implementation of evidence-based genomic and precision health interventions requires an understanding of what works and what doesn’t work within the context of various clinical and public...
View ArticleClik here to view.
Population-based Genomic Screening Programs: The Need for Optimal...
Population genomic screening of adults has emerged as a strategy to promote prevention of common diseases such as cancer and heart disease among persons with genetic conditions. This type of screening...
View ArticleClik here to view.
Data for Action in Public Health Genomics: Ensuring Equitable Implementation...
In the more than 20 years since the completion of the Human Genome Project, basic and clinical research have delivered on the promise to develop genomic applications that can help prevent and treat...
View ArticleClik here to view.
The Promise of Population-based Genomic Screening for Selected Hereditary...
It is estimated that 3 million people in the United States carry pathogenic variants that increase their risks for heart disease and cancer. If people with such variants are identified, medical...
View ArticleClik here to view.
Persistent Underutilization of BRCA Testing for Breast and Ovarian Cancer in...
Two recent studies document ongoing underutilization and disparities in genetic testing for patients with breast and ovarian cancer. BRCA1 and BRCA2 (BRCA) genetic testing is supported by clinical...
View ArticleClik here to view.
Get up to Speed on the Latest Developments in the Field! Register for the...
Advances in genomics, data science, machine learning, and artificial intelligence are transforming practice. Next generation public health and medical workforces need to understand these developments...
View Article
